Drug Formulary Review articles from July 2009

Drug Formulary Review archives from July 2009

Hospital pharmacies find budgeting a challenging process this year.(Report)
July 1, 2009... Hospital pharmacies find budgeting a challenging process this year Lower bed counts, state budget cuts have impact Hospitals from coast to coast are finding it more challenging to handle budgeting this year because of a variety of...

Hospital budget cuts can result in changes.(Report)
July 1, 2009... Hospital budget cuts can result in changes IT efficiencies can help Not every hospital pharmacy has experienced budget cuts this year, but with the prolonged economic downturn this is a possibility for everyone. The pharmacy at...

H1N1 flu is slowing down, gives room to front-line.
July 1, 2009... H1N1 flu is slowing down, gives room to front-line So far, so good -- but what's next? [Editor's note: Drug Formulary Review presents a look at how pharmacy disaster planning experts have handled the recent novel H1N1 influenza A...

Antiviral influenza drug guidance.
July 1, 2009... Antiviral influenza drug guidance Here's what HHS recommends The U. S. Department of Health and Human Services has extensive guidelines on how health care providers and public health agencies should handle an influenza pandemic. ...

Here's a sample H1N1 flu situation report.
July 1, 2009... Here's a sample H1N1 flu situation report Sarasota County keeps everyone in loop During the early weeks of the H1N1 flu outbreak, the Florida Department of Health and Sarasota County kept health care providers and others apprised of...

Stocking emergency medications: research first.
July 1, 2009... Stocking emergency medications: Research first Find the treatments most needed for area Stocking antidotes and other rarely-used emergency medications is almost an afterthought at many hospitals. "A lot of these are drugs that are...

Drug News.(FDA issues alert, revisions for prescribing ceftriaxone)
July 1, 2009... FDA issues alert, revisions for prescribing ceftriaxone The FDA has revised information about ceftriaxone (Rocephin.sup.[R]) regarding its interaction with calcium-containing products. Here are the FDA's recommendations: ...